Benzinga | Nov 18, 2021 10:23AM EST

UPDATE: 'Insurers Balk at Paying for Biogen's $56,000-a-Year Alzheimer's Treatment' -Recent Bloomberg Report

https://www.bloomberg.com/news/articles/2021-11-18/biogen-biig-alzheimer-s-drug-aduhelm-not-embraced-by-insurance-companies